Product Information
CEFPODOXIME 200 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $1.3724 per EA under NDC 67877087920. Its NADAC has been published 184 times since Mar 29, 2023.
FDA first approved this application on May 18, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877087920
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFPODOXIME PROXETILApproval Type
Generic (ANDA)
FDA Application
ANDA210568FDA Approved
5/18/2022
TE Code
AB
On Market Since
2/13/2023
Pharmacological Classes
Price Statistics
The NADAC for CEFPODOXIME 200 MG TABLET has been published 184 times since Mar 29, 2023, and over the history we have for it it has declined 45.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3724 per EA |
|---|---|
| All-time high | $2.7389 (May 10, 2023) |
| All-time low | $1.3457 (Aug 19, 2026) |
| 52-week high | $1.6971 |
| 52-week low | $1.3457 |
| Median price | $1.7961 |
| Average price | $1.9073 |
| Largest weekly change | -33.3% (Apr 17, 2024) |
| Weeks tracked | 184 |
| Tracking since | Mar 29, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefpodoxime Proxetil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFPODOXIME 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPODOXIME 200 MG TABLET, manufactured by Ascend Laboratories, LLC, is $1.3724 per EA (NDC 67877087920), effective Sep 30, 2026.
How has the price of CEFPODOXIME 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPODOXIME 200 MG TABLET has declined 45.4%. It has been tracked across 184 weekly CMS publications since Mar 29, 2023.
What are the highest and lowest recorded NADAC prices for CEFPODOXIME 200 MG TABLET?
Since Mar 29, 2023, the NADAC for CEFPODOXIME 200 MG TABLET has ranged from a low of $1.3457 (Aug 19, 2026) to a high of $2.7389 (May 10, 2023), with a median of $1.7961 per EA.
Are there cheaper alternatives to CEFPODOXIME 200 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFPODOXIME 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFPODOXIME 200 MG TABLET?
CEFPODOXIME 200 MG TABLET (NDC 67877087920) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.